✦ LIBER ✦

Image Quality Assurance in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Network of the National Lung Screening Trial

✍ Scribed by Stephen M. Moore; David S. Gierada; Kenneth W. Clark; G. James Blaine

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 768 KB
Volume: 18
Category: Article
ISSN: 0897-1889
DOI: 10.1007/s10278-005-5153-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female

A national cancer institute sponsored sc

A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

✍ Barnett S. Kramer; John Gohagan; Philip C. Prorok; Charles Smart 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Background. Ovarian cancer is the fifth most common cause of cancer-related death in American women. The median age at diagnosis is about 62 years; incidence rises rapidly after age 60. Pelvic examination has been the primary method for detection of ovarian carcinoma. It is insensitive for the detec

Diabetes mellitus and prostate cancer ri

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

✍ Michael F. Leitzmann; Jiyoung Ahn; Demetrius Albanes; Ann W. Hsing; Arthur Schat 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 246 KB

Adherence to repeat screening flexible s

Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

✍ Joel L. Weissfeld; Bruce S. Ling; Robert E. Schoen; Robert S. Bresalier; Thomas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND Acceptance of screening flexible sigmoidoscopy has been poor, in part because of providers' concerns regarding the acceptability of the procedure. In the current prospective study, the authors used adherence to repeat testing to assess the acceptability of screening flexi

Large-scale randomized prostate cancer s

Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

✍ Harry J. de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 79 KB 👁 2 views

## Abstract Two large‐scale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe are currently under way, aimed at assessing whether screening reduces prostate cancer mo

IGF-1 and IGFBP-3: Risk of prostate canc

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

✍ Jocelyn M. Weiss; Wen-Yi Huang; Sabina Rinaldi; Thomas R. Fears; Nilanjan Chatte 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 1 views

## Abstract IGF‐1 and IGFBP‐3 may influence risk of prostate cancer through their roles in cellular growth, metabolism and apoptosis, however, epidemiologic results have been inconsistent. The role of obesity in prostate cancer risk is not clearly understood, but hyperinsulinemia‐related increases